PACTR202306562134107
Recruiting
未知
Efficacy of Cerebrolysin as an Adjuvant Therapy Following Mechanical Thrombectomy in Patients with Large Vessel Occlusion Stroke
Ain Shams University hospital0 sites50 target enrollmentApril 12, 2023
ConditionsNervous System Diseases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Nervous System Diseases
- Sponsor
- Ain Shams University hospital
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with acute cardioembolic stroke as defined by TOAST classification.
- •\-Evidence of large vessel occlusion
- •\-NIHSS \=10,
- •\- Underwent successful mechanical thrombectomy ± IV thrombolysis, after fulfilling the standard eligibility criteria.
Exclusion Criteria
- •\-Patients aged more than 80 years old
- •\-Patients with epilepsy
- •\-Patients who are pregnant or lactating
- •\-Patients serious, advanced, or terminal illness or life expectancy \= 6 months
- •\-Patients with bleeding tendency or platelet count less than 100,000/uL
- •\-Patients with high INR above 1\.7
- •\-Patient receiving low molecular weight heparin therapy less than 24 hours of stroke onset.
- •\-Patient with premorbid cognitive impairment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The efficacy of Cerebrolysin in the treatment of acute ischemic strokeCerebral infarction.Cerebral infarctionIRCT138803272042N1Research Deputy, Shahid Beheshti University of Medical Sciences100
Active, not recruiting
Phase 1
Is Cerebrolysin efficient in neurorecovery after moderate-severe traumatic brain injury?Moderate-severe traumatic brain injuryMedDRA version: 26.1Level: LLTClassification code 10060690Term: Traumatic brain injurySystem Organ Class: 10022117 - Injury, poisoning and procedural complicationsTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2022-003382-38-ROFSNANO05012022440
Unknown
Phase 2
Feasibility study of Cerebrolysin therapy in pre-hospital treatment of patients with acute strokeEarlier treatment after stroke onset improves long-term outcome. Pre-hospital treatment for stroke will be an important part of future stroke treatment. Early administration of neuroprotective agents could be beneficial for stroke patientscerebrolysin, ambulance, mobile stroke unit, strokeTCTR20220310004Chulalongkorn Stroke Center20
Completed
Phase 2
Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosisISRCTN38393880Instituto Cardiológico Banfield20
Completed
Not Applicable
Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapyAcute ischemic strokeCirculatory SystemStroke, not specified as haemorrhage or infarctionISRCTN15233803niversity Hospital Centre Zagreb46